internationally, primarily the United States. With a wide ranging Alkem Laboratories Ltd. (ALL) is present across acute and chronic therapeutic segments with substantial brand share in the Anti-infective, Gastro-intestinal, Pain Management, Vitamins / Minerals / Nutritions, Central Nervous System, Anti-diabetic, Anti-osteoporosis, Anti-malarial, Cardiovascular, Immunosuppressant, and Nutraceutical segments. ALL has developed a portfolio of 736 branded generic drugs and command market leadership, with 13 of the brands featured among the top 300 brands in India for the fiscal year 2015. ALL has 16 manufacturing facilities, 14 in India and 2 in US. 5 of facilities are US FDA,...